Dosage and kinetics of MMC release of a collagen implant used as a delivery device in glaucoma surgery in the rabbit eye;Dosage et cinétique de libération de mitomycine C d'un implant de collagène utilisé comme moyen d'administration lors d'une chirurgie filtrante chez le lapin

Journal Francais d'Ophtalmologie

Volumn 29, Issue 9, 2006, Pages 1042-1046

  Adjadj, E ^a,c   Roy, S ^a   Zimmermann, C ^b   Shaarawy, T ^b   Flammer, J ^b   Mermoud, A ^a   Drewe, J ^b  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b Department of Obstetrics and Gynaecology   (Switzerland)

^c HÔPITAL OPHTALMIQUE JULES GONIN   (Switzerland)

Author keywords

Antimetabolites; Collagen absorbable implants; Filtering surgery; Glaucoma

Indexed keywords

COLLAGEN IMPLANT; MITOMYCIN C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOASSAY; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG RELEASE; GLAUCOMA SURGERY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; QUANTITATIVE ANALYSIS; RABBIT; SCLERA; SPECTROPHOTOMETRY;

EID: 33751579327     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0181-5512(06)73893-1     Document Type: Article

References (25)

1. Mermoud A, Salmon JF, Murray AD. Trabeculectomy with mitomycin C for refractory glaucoma in blacks. Am J Ophthalmol, 1993;116:72-8.
2. Neudorfer M, Sadetzki S, Anisimova S, Geyer O. Nonpenetrating deep sclerectomy with the use of adjunctive mitomycin C. Ophthalmic Surg Lasers Imaging, 2004;35:6-12.
3. Wilkins M, Indar A, Wormald R. Intra-operative mitomycin C for glaucoma surgery. Cochrane Database Syst Rev, 2001:CD002897.
4. Tsai JC, Chang HW, Kao CN, Lai IC, Teng MC. Trabeculectomy with mitomycin C versus trabeculectomy alone for juvenile primary open-angle glaucoma. Ophthalmologica, 2003;217:24-30.
5. Iester M, Ravinet E, Mermoud A. Postoperative subconjunctival mitomycin-C injection after non-penetrating glaucoma surgery. J Ocul Pharmacol Ther, 2002;18:307-12.
6. Laube T, Ritters B, Selbach M, Hudde T. [Clinical experiences and results of application of mitomycin C in trabeculectomy]. Klin Monatsbl Augenheilkd, 2003;220:618-24.
7. Mietz H. The toxicology of mitomycin C on the ciliary body. Curr Opin Ophthalmol, 1996;7:72-9.
8. Akova YA, Koc F, Yalvac I, Duman S. Scleromalacia following trabeculectomy with intraoperative mitomycin C. Eur J Ophthalmol, 1999;9:63-5.
9. DeBry PW, Perkins TW, Heatley G, Kaufman P, Brumback LC. Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin. Arch Ophthalmol, 2002;120:297-300.
10. Diestelhorst M, Krieglstein GK. [Effect of mitomycin C on aqueous humor flow after trabeculectomy]. Ophthalmologe, 1995;92:542-5.
11. Schraermeyer U, Diestelhorst M, Bieker A, Theisohn M, Mietz H, Ustundag C, et al. Morphologic proof of the toxicity of mitomycin C on the ciliary body in relation to different application methods. Graefes Arch Clin Exp Ophthalmol, 1999;237:593-600.
12. Mietz H, Rump AF, Theisohn M, Klaus W, Diestelhorst M, Krieglstein GK. Ocular concentrations of mitomycin C after extraocular application in rabbits. J Ocul Pharmacol Ther, 1995;11:49-55.
13. Mietz H, Diestelhorst M, Rump AF, Theisohn M, Klaus W, Krieglstein GK. Ocular concentrations of mitomycin C using different delivery devices. Ophthalmologica, 1998;212:37-42.
14. Georgopoulos M, Vass C, Vatanparast Z. Impact of irrigation in a new model for in vitro diffusion of mitomycin-C after episcleral application. Curr Eye Res, 2002;25:221-5.
15. Georgopoulos M, Vass C, Vatanparast Z. Modifying subsceral fluid pressure in an experimental model of mitomycin-C diffusion. Exp Eye Res, 2002;75:677-81.
16. Larrosa JM, Polo V, Pinilla I, Pablo LE, Martinez MR, Abecia E, et al. Quantification of intraoperative administration of mitomycin-C in filtering surgery with surgical sponge material. J Glaucoma, 1999;8:46-50.
17. Mehel E, Weber M, Stork L, Pechereau A. A novel method for controlling the quantity of mitomycin-C applied during filtering surgery for glaucoma. J Ocul Pharmacol Ther, 1998;14:491-6.
18. Mehel E, Weber M, Stork Vabres L, Pechereau A. La quantité de Mytomicine C appliquée pendant la chirurgie filtrante du glaucoma varie-t-elle selon le chirurgien ? J Fr Ophtalmol, 1997;20:195-9.
19. Sarraf D, Eezzuduemhoi RD, Cheng Q, Wilson MR, Lee DA. Aqueous and vitreous concentration of mitomycin C by topical administration after glaucoma filtration surgery in rabbits. Ophthalmology, 1993;100:1574-9.
20. Georgopoulos M, Vass C, El Menyawi I, Radda S, Graninger W, Menapace R. In vitro diffusion of mitomycin-C into human sclera after episcleral application: impact of diffusion time. Exp Eye Res, 2000;71:453-7.
21. ARVO Statement for the use of animals in ophthalmic and visual research. (Site consulté le 25 octobre 2005). http://www.arvo.org/eweb/dynamicpage. aspx?site=arvo2&webcode=AnimalsResearch.
22. Mermoud A. La sclérectomie profonde, technique chirurgicale. J Fr Ophtalmol, 1999;22:781-6.
23. Mardelli PG, Lederer CM Jr, Murray PL, Pastor SA, Hassanein KM. Slit-lamp needle revision of failed filtering blebs using mitomycin C. Ophthalmology, 1996;103:1946-55.
24. Ben-Simon GJ, Glovinsky Y. Needle revision of failed filtering blebs augmented with subconjunctival injection of mitomycin C. Ophthalmic Surg Lasers Imaging, 2003;34:94-9.
25. Shetty RK, Wartluft L, Moster MR. Slit-lamp needle revision of failed filtering blebs using high-dose mitomycin C. J Glaucoma, 2005;14:52-6.